“Guest Editor: Pellegrino Musto HOW FIRST-LINE THERAPY IS CHANGING IN NON-TRANSPLANT ELIGIBLE MULTIPLE MYELOMA PATIENTS”. (2025) Mediterranean Journal of Hematology and Infectious Diseases, 17(1), p. e2025025. doi:10.4084/MJHID.2025.025.